Latest Tokyo Brief coverage on TAKARA HOLDINGS INC., tracking filings, financial news, and market signals from Japan.
TSE:2531
Takara Holdings pulled its August 7 earnings release after its auditor said it could not complete a quarterly review of Takara Bio USA's accounts, and the Kyoto group now expects to miss the standard 45-day disclosure deadline with no new date set.
148 employees took Takara Bio's voluntary retirement offer against a target of about 120, lifting the one-off charge to ¥1.71bn, while the delisted biotech signs a basic agreement to hand its GMP cell-processing business to a Sumitomo Chemical and Sumitomo Pharma joint venture ahead of a target final contract in October.